Sign in

CIK 0001743881 · Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(650) 391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,563,798
in 3 filings, $4.6M under 10b5-1 plans

Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kumar Neil −$4.4M Chief Executive Officer sold 10% of stake
  2. Apuli Maricel −$146K Chief Accounting Officer sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-16 Kumar Neil CEO and President Shares withheld for taxes −23,908 $12.64 $302K 4,857,995
2023-02-16 Kumar Neil CEO and President Option exercise · Restricted Stock Units −5,129 25,647
2023-02-16 Kumar Neil CEO and President Option exercise · Restricted Stock Units −2,395 19,153
2023-02-16 Kumar Neil CEO and President Option exercise · Restricted Stock Units −61,182 244,728
2021-12-29 Valantine Hannah Director Purchase +1,752 $14.24 $25K 3,294
2021-12-28 Valantine Hannah Director Purchase +1,542 $12.68 $20K 1,542
2021-12-28 Valantine Hannah Director Purchase +796 $13.16 $10K 2,687
2021-12-28 Valantine Hannah Director Purchase +1,891 $13.18 $25K 1,891
2021-12-28 Valantine Hannah Director Purchase +1,542 $12.68 $20K 3,433
2021-11-16 Cook Jennifer E. Director Option exercise +3,576 7,152
2021-11-16 Cook Jennifer E. Director Option exercise · Restricted Stock Units −3,576 0
2021-02-17 KKR Genetic Disorder L.P. 10% owner Sale −3,450,000 $60.47 $208.6M 31,060,971
2020-05-28 KKR Genetic Disorder L.P. 10% owner Sale −2,389,690 $33.39 $79.8M 34,510,971
2019-07-01 KKR Genetic Disorder L.P. 10% owner Conversion +34,253,561 34,253,561
2019-07-01 KKR Genetic Disorder L.P. 10% owner Purchase +2,647,100 $17.00 $45.0M 36,900,661
2019-07-01 KKR Genetic Disorder L.P. 10% owner Conversion · Series B Preferred Units −81,022,727 0
2019-07-01 KKR Genetic Disorder L.P. 10% owner Conversion · Series C Preferred Units −36,246,893 0
2019-07-01 KKR Genetic Disorder L.P. 10% owner Conversion · Series D Preferred Units −50,446,451 0

Page 32 of 32 · 638 trades